Thursday, March 28, 2013 4:12:46 PM
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Toronto Ontario, March 28, 2013 - Nautilus Minerals Inc. (TSX: NUS, OTCQX: NUSMF) (the "Company" or "Nautilus") has today filed a preliminary short form prospectus within each province of Canada, other than Quebec, in respect of a rights offering to raise gross proceeds of C$40,000,000 through the issuance of rights to subscribe for an aggregate of 200,000,000 common shares at a subscription price of C$0.20 per common share.
One of the Company's major shareholders, MB Holding Company LLC, through a wholly owned subsidiary, has agreed to act as Standby Purchaser in respect of the full offering and will purchase all of the common shares that are not otherwise subscribed for under the offering, in consideration for a fee of C$2 million.
The net proceeds from the offering will be used by the Company to continue funding its three key contracts related to the Seafloor Production System. The key contracts include the build of the Seafloor Production Tools by Soil Machine Dynamics Ltd, the supply of the Subsea Slurry Lift Pump by GE Hydril and the procurement of the rigid riser system by General Marine Contractors LLC. The Company believes that continuing with these key contracts will ensure the Company is in the best possible position to advance the Solwara 1 Project following resolution of the dispute with the State of PNG. To that end, the Company continues to meet with senior representatives of the State, including National Executive Council Ministers, with a view to amicably resolving the dispute as soon as possible.
The offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the acceptance of the Toronto Stock Exchange.
Management of the Company will hold an investor call next week, the details of which will be provided in due course.
The prospectus is available electronically at www.sedar.com.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM